News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Agios Pharmaceuticals, Inc.
NEWS
JOBS
IN THE PRESS
AWARDS
NEWS
Biotech Bay
Top 5 Biotech Stocks to Buy for 2018
A new RBC report is reasonably positive on the biotech sector for 2018 and here are some reasons why.
December 21, 2017
·
2 min read
·
Mark Terry
FDA
Agios, Celgene Win Early FDA Approval for New Cancer Drug
August 1, 2017
·
2 min read
Drug Development
Cambridge Biotech Agios Terminates AG-519 for PK Deficiency, But Continues AG-348 For Same Condition
December 16, 2016
·
2 min read
FDA
Another Celgene Bet Pays Off as Agios Eyes Early Approval of Leukemia Drug
September 7, 2016
·
2 min read
Business
Former BIND Therapeutics CEO Joins Agios as New CFO
August 16, 2016
·
2 min read
Business
Agios, Celgene Hammer Out $1 Billion+ Metabolic Immuno-Oncology Deal
May 18, 2016
·
3 min read
Genetown
10 Massachusetts Biotechs Devoting the Most Cash to R&D
May 5, 2016
·
3 min read
Genetown
Celgene And Agios Deliver Some Great “Bad” News
June 18, 2015
·
1 min read
Business
Celgene Dealmaking Continues With Two Pacts Worth $110 Million With Agios, Northern Biologics
April 29, 2015
·
3 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Business
Agios to Webcast Conference Call of Fourth Quarter and Year End 2023 Financial Results on February 15, 2024
February 2, 2024
·
1 min read
Genetown
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
January 8, 2024
·
8 min read
Drug Development
Agios Announces Phase 3 ENERGIZE Study of Mitapivat Met Primary Endpoint and Both Key Secondary Endpoints in Adults with Non-Transfusion-Dependent Alpha- or Beta-Thalassemia
January 3, 2024
·
9 min read
Genetown
Agios to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024
January 2, 2024
·
1 min read
Drug Development
Agios Presents Positive Results from Phase 2 Portion of the RISE UP Pivotal Study in Sickle Cell Disease at 65th ASH Annual Meeting and Exposition
December 9, 2023
·
13 min read
Drug Development
Agios Announces Clinical Proof-of-Concept in Phase 2a Trial of AG-946 for the Treatment of Anemia in Lower-Risk Myelodysplastic Syndromes
November 20, 2023
·
8 min read
Genetown
Agios Pharmaceuticals to Present Broad Set of Clinical and Translational Data in Rare Blood Disorders at 65th ASH Annual Meeting and Exposition
November 2, 2023
·
15 min read
Business
Agios Reports Business Highlights and Third Quarter 2023 Financial Results
November 2, 2023
·
9 min read
Business
Agios to Webcast Conference Call of Third Quarter 2023 Financial Results on Nov. 2, 2023
October 19, 2023
·
1 min read
Genetown
Agios to Present at the Morgan Stanley Global Healthcare Conference on September 12, 2023
August 29, 2023
·
1 min read
